Clinical Trials Logo

Clinical Trial Summary

To evaluate effectiveness and safety of HHRS in subjects undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, clinical, radiologic, and radiostereometric outcomes. Safety will be evaluated through the collection of device-related and unanticipated device-related adverse events.


Clinical Trial Description

The HIT Hip Replacement System (HHRS) is a Metal-on-Polyethylene (MoP) conventional hip prosthesis. The HHRS consists of a femoral stem, an acetabular cup and a Cobalt Chromium Molybdenum (CoCrMo) ball that articulates within a polyethylene liner. The ball sits on the acetabular cup, and the polyethylene liner is attached to the femoral cup, which attaches to the femoral stem, instead of the acetabular cup. The acetabular component of the HHRS consists of a hemispherical acetabular shell with a clustered screw-hole design. The outside of the shells are coated with titanium plasma to facilitate bone in-growth and provide secure intermediate fixation with the prepared bone surface at the site of implantation. The acetabular cup has a 3-hole design that accommodates three titanium alloy bone screws. Inside the acetabular cup is a male taper for assembly with the acetabular ball. The femoral component consists of a femoral stem manufactured from titanium and a mating cobalt chrome femoral cup lined with a highly cross-linked ultra-high-molecular-weight polyethylene (UHMWPE). As with the acetabular cup, the femoral stem is porous coated using a plasma spray of pure titanium, which is intended to facilitate bone in-growth and provide secure intermediate fixation with the prepared bone surface at the site of implantation. The femoral stem incorporates a female taper for assembly with the male taper of the femoral cup. The device has undergone extensive pre-clinical testing. There is no clinical experience with the HRS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02836262
Study type Interventional
Source Hip Innovation Technology
Contact Linda Braddon, PhD
Phone 770-837-2681
Email LGB@SecureBME.com
Status Recruiting
Phase N/A
Start date August 25, 2017
Completion date August 25, 2026

See also
  Status Clinical Trial Phase
Completed NCT02405104 - Chlorzoxazone in Hip and Knee Arthroplasty Phase 4
Completed NCT02162186 - Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
Active, not recruiting NCT02263209 - Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty N/A
Completed NCT02577822 - The Viability of Short Stems in Total Hip Arthroplasty N/A
Active, not recruiting NCT00551967 - Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA N/A
Active, not recruiting NCT00545285 - Long-Term Multi-center Evaluation of E-Poly and Regenerex N/A
Completed NCT03966573 - Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints N/A
Recruiting NCT04754087 - G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study N/A
Completed NCT00957970 - Bone Mineral Changes Around Stemless and Stemmed Cementless Femoral Components Phase 4
Completed NCT00565786 - ArCom® and ArComXL® Polyethylene Data Collection
Completed NCT03428893 - Mobile Technology to Support Physical Therapy Exercise N/A
Completed NCT01972594 - Pedometer Based Intervention After Total Hip Replacement-A Pilot Study N/A
Terminated NCT02161484 - Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement N/A
Withdrawn NCT01668160 - Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis N/A
Not yet recruiting NCT01040273 - Management of Postoperative Pain After Total Hip Arthroplasty Phase 2/Phase 3
Completed NCT03341442 - A Study of Posterior Hip Precautions After Total Hip Arthroplasty N/A